» Articles » PMID: 26940107

Point-of-care C Reactive Protein for the Diagnosis of Lower Respiratory Tract Infection in NHS Primary Care: a Qualitative Study of Barriers and Facilitators to Adoption

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Mar 5
PMID 26940107
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Point-of-care (POC) C reactive protein (CRP) is incorporated in National Institute of Health and Care Excellence (NICE) guidelines for the diagnosis of pneumonia, reduces antibiotic prescribing and is cost effective.

Aim: To determine the barriers and facilitators to adoption of POC CRP testing in National Health Service (NHS) primary care for the diagnosis of lower respiratory tract infection.

Design: The study followed a qualitative methodology based on grounded theory. The study was undertaken in 2 stages. Stage 1 consisted of semistructured interviews with 8 clinicians from Europe and the UK who use the test in routine practice, and focused on their subjective experience in the challenges of implementing POC CRP testing. Stage 2 was a multidisciplinary-facilitated workshop with NHS stakeholders to discuss barriers to adoption, impact of adoption and potential adoption scenarios. Emergent theme analysis was undertaken.

Participants: Participants included general practitioners (including those with commissioning experience), biochemists, pharmacists, clinical laboratory scientists and industry representatives from the UK and abroad.

Results: Barriers to the implementation of POC CRP exist, but successful adoption has been demonstrated abroad. Analysis highlighted 7 themes: reimbursement and incentivisation, quality control and training, laboratory services, practitioner attitudes and experiences, effects on clinic flow and workload, use in pharmacy and gaps in evidence.

Conclusions: Successful adoption models from the UK and abroad demonstrate a distinctive pattern and involve collaboration with central laboratory services. Incorporating antimicrobial stewardship into quality improvement frameworks may incentivise adoption. Further research is needed to develop scaling-up strategies to address the resourcing, clinical governance and economic impact of widespread NHS implementation.

Citing Articles

Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care tests.

Vogler S, Steigenberger C, Windisch F Health Policy Open. 2024; 7:100129.

PMID: 39430908 PMC: 11488418. DOI: 10.1016/j.hpopen.2024.100129.


Point-of-care tests to manage acute respiratory tract infections in primary care: a systematic review and qualitative synthesis of healthcare professional and patient views.

Hoste M, Borek A, Santillo M, Roberts N, Tonkin-Crine S, Anthierens S J Antimicrob Chemother. 2024; 80(1):29-46.

PMID: 39378128 PMC: 11695907. DOI: 10.1093/jac/dkae349.


[Audit of Antibiotic Dispensing in Community Pharmacy (Happy Patient Project)].

Plaza Zamora F, Mendoza Barbero A, Molinero A, Sanchez Marcos N, Lambert M, Taxis K Farm Comunitarios. 2024; 15(4):26-36.

PMID: 39156980 PMC: 11326684. DOI: 10.33620/FC.2173-9218.(2023).28.


Improving healthcare professionals' interactions with patients to tackle antimicrobial resistance: a systematic review of interventions, barriers, and facilitators.

Ayorinde A, Ghosh I, Shaikh J, Adetunji V, Brown A, Jordan M Front Public Health. 2024; 12:1359790.

PMID: 38841670 PMC: 11150712. DOI: 10.3389/fpubh.2024.1359790.


Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study.

Wilcox C, Odeh N, Clark T, Muller I, Becque T, Todd A J Antimicrob Chemother. 2024; 79(6):1441-1449.

PMID: 38708643 PMC: 11144485. DOI: 10.1093/jac/dkae127.


References
1.
Smucny J, Fahey T, Becker L, Glazier R . Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004; (4):CD000245. DOI: 10.1002/14651858.CD000245.pub2. View

2.
Huddy J, Ni M, Mavroveli S, Barlow J, Williams D, Hanna G . A research protocol for developing a Point-Of-Care Key Evidence Tool 'POCKET': a checklist for multidimensional evidence reporting on point-of-care in vitro diagnostics. BMJ Open. 2015; 5(7):e007840. PMC: 4499707. DOI: 10.1136/bmjopen-2015-007840. View

3.
Cals J, Butler C, Hopstaken R, Hood K, Dinant G . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009; 338:b1374. PMC: 2677640. DOI: 10.1136/bmj.b1374. View

4.
Butler C, Hood K, Verheij T, Little P, Melbye H, Nuttall J . Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009; 338:b2242. PMC: 3272656. DOI: 10.1136/bmj.b2242. View

5.
Cals J, Chappin F, Hopstaken R, van Leeuwen M, Hood K, Butler C . C-reactive protein point-of-care testing for lower respiratory tract infections: a qualitative evaluation of experiences by GPs. Fam Pract. 2009; 27(2):212-8. DOI: 10.1093/fampra/cmp088. View